Hidde J. Haisma

9.1k total citations · 1 hit paper
171 papers, 7.2k citations indexed

About

Hidde J. Haisma is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Hidde J. Haisma has authored 171 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 55 papers in Radiology, Nuclear Medicine and Imaging and 54 papers in Oncology. Recurrent topics in Hidde J. Haisma's work include Virus-based gene therapy research (51 papers), Monoclonal and Polyclonal Antibodies Research (44 papers) and CAR-T cell therapy research (30 papers). Hidde J. Haisma is often cited by papers focused on Virus-based gene therapy research (51 papers), Monoclonal and Polyclonal Antibodies Research (44 papers) and CAR-T cell therapy research (30 papers). Hidde J. Haisma collaborates with scholars based in Netherlands, United States and Germany. Hidde J. Haisma's co-authors include Gert Storm, Amir K. Varkouhi, Frank J. Dekker, Herbert M. Pinedo, Epie Boven, Winald R. Gerritsen, David T. Curiel, Victor W. van Beusechem, Massimo Ghizzoni and Bin Liu and has published in prestigious journals such as Nucleic Acids Research, Blood and The Journal of Immunology.

In The Last Decade

Hidde J. Haisma

167 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endosomal escape pathways for delivery of biologicals

2010 1.3k citations Hidde J. Haisma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hidde J. Haisma Netherlands	46	4.4k	1.7k	1.6k	990	830	171	7.2k
Pinku Mukherjee United States	45	3.0k 0.7×	2.1k 1.2×	797 0.5×	590 0.6×	1.9k 2.3×	122	6.8k
Jer‐Tsong Hsieh United States	63	7.5k 1.7×	3.4k 2.0×	2.0k 1.3×	700 0.7×	897 1.1×	267	12.9k
Iduna Fichtner Germany	49	3.9k 0.9×	2.9k 1.7×	597 0.4×	808 0.8×	964 1.2×	242	8.1k
Bruce R. Zetter United States	61	7.9k 1.8×	2.5k 1.5×	803 0.5×	681 0.7×	1.6k 2.0×	154	13.5k
L. Clifton Stephens United States	52	3.5k 0.8×	2.4k 1.4×	717 0.4×	1.3k 1.3×	598 0.7×	192	8.8k
Martin Clynes Ireland	53	5.7k 1.3×	2.8k 1.7×	757 0.5×	538 0.5×	831 1.0×	300	9.0k
Grietje Molema Netherlands	56	4.9k 1.1×	1.3k 0.8×	618 0.4×	908 0.9×	1.6k 1.9×	229	10.3k
Tilman M. Hackeng Netherlands	53	3.5k 0.8×	1.1k 0.7×	632 0.4×	864 0.9×	1.8k 2.2×	213	9.8k
Teni Boulikas United States	36	4.8k 1.1×	1.6k 1.0×	870 0.5×	291 0.3×	519 0.6×	77	7.7k
Steve R. Roffler Taiwan	42	3.4k 0.8×	1.3k 0.8×	598 0.4×	975 1.0×	1.2k 1.4×	168	6.1k

Countries citing papers authored by Hidde J. Haisma

Since Specialization

Citations

This map shows the geographic impact of Hidde J. Haisma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidde J. Haisma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidde J. Haisma more than expected).

Fields of papers citing papers by Hidde J. Haisma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidde J. Haisma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidde J. Haisma. The network helps show where Hidde J. Haisma may publish in the future.

Co-authorship network of co-authors of Hidde J. Haisma

This figure shows the co-authorship network connecting the top 25 collaborators of Hidde J. Haisma. A scholar is included among the top collaborators of Hidde J. Haisma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidde J. Haisma. Hidde J. Haisma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Deng, Chunlong Zhao, Jianqiu Zhang, et al.. (2024). Small Molecule MIF Modulation Enhances Ferroptosis by Impairing DNA Repair Mechanisms. Advanced Science. 11(32). e2403963–e2403963. 7 indexed citations

Liu, Bin, Siwei Chen, Deng Chen, et al.. (2019). Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing. Nucleic Acids Research. 48(2). 517–532. 281 indexed citations

Liu, Bin, Shanshan Song, Rita Setroikromo, et al.. (2019). CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor. Cancers. 11(4). 455–455. 16 indexed citations

Moen, Maarten H., et al.. (2017). No evidence for the use of stem cell therapy for tendon disorders: a systematic review. British Journal of Sports Medicine. 51(13). 996–1002. 43 indexed citations

Haisma, Hidde J.. (2011). Endosomal escape pathways for delivery of biologicals. Data Archiving and Networked Services (DANS). 1 indexed citations

Haisma, Hidde J., et al.. (2007). Poly I prevents adenoviral vector clearance by Kupffer cells and increases efficiency in gene therapy applications. Human Gene Therapy. 18(10). 981–982. 2 indexed citations

Kärpänen, Terhi, Maria Wirzenius, Taija Mäkinen, et al.. (2006). Lymphangiogenic Growth Factor Responsiveness Is Modulated by Postnatal Lymphatic Vessel Maturation. American Journal Of Pathology. 169(2). 708–718. 109 indexed citations

Harmsen, Martin C., et al.. (2005). The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context. Cancer Gene Therapy. 13(2). 150–158. 8 indexed citations

Rots, Marianne G., Willemijn M. Gommans, Igor P. Dmitriev, et al.. (2004). A platform for constucting infectivity-enhanced fiber-mosaic adenoviruses genetically modified to express two fiber types. University of Groningen research database (University of Groningen / Centre for Information Technology). 8. 1–8. 6 indexed citations

10.

Nevalainen, Tapio, et al.. (2004). A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapy. Biochemical Pharmacology. 68(11). 2273–2281. 28 indexed citations

11.

Gruijl, Tanja D. de, Sylvia A. Luykx‐de Bakker, Bryan Tillman, et al.. (2002). Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors. The Journal of Immunology. 169(9). 5322–5331. 52 indexed citations

12.

Haisma, Hidde J., Jacques Grill, David T. Curiel, et al.. (2000). Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Therapy. 7(6). 901–904. 122 indexed citations

13.

Haisma, Hidde J., et al.. (1995). A Monoclonal Antibody against Human β-Glucuronidase for Application in Antibody-Directed Enzyme Prodrug Therapy. Hybridoma. 14(4). 377–382. 10 indexed citations

14.

Buist, Marrije R., Peter Kenemans, Gerard J. van Kamp, & Hidde J. Haisma. (1995). Minor human antibody response to a mouse and chimeric monoclonal antibody after a single i.v. infusion in ovarian carcinoma patients: a comparison of five assays. Cancer Immunology Immunotherapy. 40(1). 24–30. 19 indexed citations

15.

Herscheid, Jacobus D. M., et al.. (1994). High yield production of pure 89Zr; A positron emitter for labelling of proteins. Journal of Labelled Compounds and Radiopharmaceuticals. 35. 264–266. 2 indexed citations

16.

Vingerhoeds, Monique H., et al.. (1993). A new application for liposomes in cancer therapy. FEBS Letters. 336(3). 485–490. 41 indexed citations

17.

Quak, Jasper J., Alfons J. M. Balm, J. G. P. Brakkee, et al.. (1989). Localization and imaging of radiolabelled monoclonal antibody against squamous‐cell carcinoma of the head and neck in tumor‐bearing nude mice. International Journal of Cancer. 44(3). 534–538. 21 indexed citations

18.

Haisma, Hidde J., et al.. (1988). Biodistribution, pharmacokinetics and imaging of131I-labelled OC125 in ovarian cancer. International Journal of Cancer. 41(S2). 109–113. 21 indexed citations

19.

Haisma, Hidde J., et al.. (1986). IMMUNE-COMPLEXES OF OC125-CA125 FOLLOWING INTRAVENOUS-INJECTION OF THE RADIOLABELED MONOCLONAL-ANTIBODY INTO OVARIAN-CANCER PATIENTS. Data Archiving and Networked Services (DANS). 54(3). 533–534. 2 indexed citations

20.

Haisma, Hidde J., et al.. (1985). IODINATION OF MONOCLONAL-ANTIBODIES FOR DIAGNOSIS AND RADIOTHERAPY USING A CONVENIENT ONE VIAL METHOD. University of Groningen research database (University of Groningen / Centre for Information Technology). 52(4). 645–645. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact